A ground-breaking new PCR test that identifies women with womb cancer from a sample taken from the cervix or vagina has been developed by Professor Martin Widschwendter (UCL EGA Institute of Women’s Health) and researchers from the University of Innsbruck.
Read: Sun, More: Evening Standard
Close
